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Background: The 6-min walk test (6MWT) is a submaximal exercise test used to assess func-
tional status in patients with cardiopulmonary diseases. Regression equations have previously
been published as a normal reference for 6-min walk distance (6MWD) in healthy Caucasian
adults. However, a recent study showed that the normal predicted 6MWD could differ among
ethnic populations. The aim of this study was: (1) to determine the normal 6MWD in a sample
of healthy Saudi adults; (2) to create a regression equation for the established 6MWD; and (3)
to compare the 6MWD in the present study with previously published equations.
Method: The 6MWT was administered to 298 healthy volunteers (53% males) between the ages
of 16 and 50 years.
Result: The average 6MWD was 409  51 m, with longer distances walked by males
(429  47 m) than by females (386  45 m) (p < 0.001). The regression equation revealed that
height (p < 0.001) and age (pZ 0.034) were the most significant predictors of distance
(6MWDZ (2.81  height) þ (0.79  age)  28.5). In addition, the equation explained 25% of
the distance variance. All previously published equations overestimated the Saudi 6MWD by
109e340 m.
Conclusion: Saudi populations have significantly shorter 6MWDs than those reported for other
ethnic groups. Thus, the Caucasian reference value for the 6MWD should not be used in Saudi
subjects, as it overestimates the distance and may interfere with the therapeutic and prog-
nostic value of the test.
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Objective measurements of exercise are important tools to
assess patients with cardiopulmonary disease. Cardiopul-
monary exercise tests are the standard methods for
measuring exercise capacity, particularly with regards to
physical limitation, disease prognosis and responsiveness to
treatment. These tests are sensitive and specific but.
1042 H. Alameri et al.require sophisticated equipment, trained technicians and
complex data analysis. As an alternative, time-based walk
tests are commonly used to assess exercise capacity in
patients with cardiopulmonary disease. The 6-min walk test
(6MWT) is a self-based walking test that measures the
distance walked over a period of 6-min. This test requires
a 30 m hallway, and does not require exercise equipment or
highly trained technicians. Several studies have reported
that 6-min walk distance (6MWD) correlates strongly with
variables measured by the cardiopulmonary exercise test,
such as maximum oxygen consumption and ventilatory
parameters.1e4 Subsequent studies have found the 6MWD to
be a good predictor of morbidity among patients with
pulmonary or cardiac diseases.3,5e9
Variabilities in physical capacity and exercise perfor-
mance can be determined by measuring cardiopulmonary
endurance, musculoskeletal function and body composi-
tion. By themselves, these components can be affected by
other factors, including age, gender, height, weight,
genotype and race. Normal predicted values for 6MWD are
based on age, gender, height and weight. Such values are
widely used as references for 6MWD in Caucasian healthy
adults.10e13 However, a small number of studies have
reported differences in the normal predicted 6MWDs of
other ethnic populations. Poh and associates reported that
the normal 6MWD of 35 healthy Singaporean Chinese were
75 m less than those reported for Caucasians14.
Previous reports examining the utility of the 6MWT
showed that the test could be an additive tool to assess
disease severity and response to treatment, or to predict
mortality in patients with several cardiopulmonary
diseases. For example, in patients with heart failure or
pulmonary hypertension, a 6MWD less than 300 m was an
independent predictor of mortality.3,6 In another study,
a change in 6MWD of 54 m or more reflected a meaningful
change in functional status of patients with COPD.15 Our
laboratory previously reported the mean 6MWD of a group
of Saudi patients with respiratory disease. Although these
patients experienced mild ventilatory impairments, their
walked distances were significantly shorter than those
reported for Western populations.16 These results suggest
that Western 6MWD reference values may be subject to
misinterpretation when applied to our populations, and can
provide misleading information with regards to therapeutic
or prognostic determinants.
Therefore, our study sought to evaluate the distances
walked by randomly selected healthy female and male
Saudi subjects. In addition, this study examined potential
6MWD-predictive variables in the Saudi population. We
have also examined the differences in walking distances of
our cohort and previously published equations.Methods
Healthy Saudi volunteers between the ages of 18 and
50 years were randomly recruited to participate in this
descriptive, prospective, cross-sectional population based
study. The study was conducted in Riyadh city, the capital
of Saudi Arabia, with an estimated population of over 5
million inhabitants. In order to get a citywide representa-
tive sample, the studied population was selected from thecentral, northern and southern parts of the city and rep-
resented both the public and private sectors. Study
subjects were teachers from three public schools, students,
workers and visitors of a local university and employees of
a local private company. All subjects provided formal
consent, and the study design was approved by the King
Saud University Research Committee and the Scientific
Review Board of the Department of Medicine. Subjects
were excluded from the study if they had medical histories
that were indicative of cardiovascular or pulmonary
disease, current or past histories of smoking,17 upper
respiratory tract infections within the last 4 weeks, condi-
tions that could affect walking, resting blood pressures
higher than 140/90 mmHg, heart rates higher than 100
beats per min, body mass indexes (BMIs) greater than 35 or
evidence of ventilatory impairment as measured by
spirometry (i.e., forced expiratory volume in 1 s, FEV1,
values lower than 80%, and FEV1/FVC (forced vital capacity)
values lower than 70%, of normal predicted value).
Six-min walk test
Participants were asked to eat a light morning meal and to
wear comfortable clothes and shoes. Tests were conducted
at five different sites between 9:00 a.m. and 1:00 p.m.
Height and weight were measured using a calibrated scale
and body mass indices for each subject were calculated.
Heart rate, blood pressure and oxygen saturation were
measured using the 506N3 Vital Signs Monitor (Criticare
Systems, WI, USA) during a 10e15-min resting period before
the test. Subjects were asked to indicate their level of
dyspnea perception using a modified 12 point Borg scale,
wherein each score (i.e., ranging from 0 to 10) is illustrated
by a printed figure. Each subject performed a single 6MWT
in a quiet, air-conditioned building containing a 30 m-long
corridor with marks at 1 m intervals.18 Subjects were asked
to walk as far down the length of the corridor as they could,
at their own pace, for 6-min. Subjects were informed of the
time elapsed every 60 s, using standardized phrases.19
Subjects were allowed to stop if they developed symptoms
of dyspnea, chest pain, leg cramps or dizziness, but were
encouraged to continue walking as soon as they could. At
the end of the test, each subject’s heart rate, blood pres-
sure, oxygen saturation and Borg value was measured, and
the maximum predicted heart rate (mHR) was calculated
(mHRZ 220 e age). All tests were conducted and super-
vised by the same technician at each of the five sites.
Spirometry
Spirometry was performed using a standard portable
spirometer (Vitalograph alpha, Ireland) that was calibrated
on a daily basis. Patients were asked to perform at least
three measures, and the largest value was recorded for
analysis as recommended by the guidelines of the American
Thoracic Society.20
Statistical analysis
Data was analyzed using the SPSS statistical software
package (SPSS version 13.0, Chicago, IL). Descriptive
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graphic and clinical parameters. Student’s t-tests were
used to compare female and male subjects. Six-min walk
distances were correlated with patients’ ages, heights,
weights, BMIs, heart rates, Borg scores, and FVC and FEV1
values using the Spearman rank correlation coefficient.
A stepwise linear regression model was used to determine if
any of the above variables were independent predictors of
6MWD. Approximately 80% of the studied population was
randomly selected for inclusion in a predictive equation,
while the remaining subjects were used as controls. The
regression equation was validated by comparing the actual
distance walked by the control group with the predicted
distance determined by the equation. The mean 6MWD
measured of the whole group in our study was compared to
the mean distance calculated using each of the five previ-
ously published equations of Troosters,10 Gibbons,12
Camarri,13 Enright,11 and Poh.14 A paired sample t-test was
used to compare two means. Values were considered
statistically significant if p < 0.05.
Results
The baseline characteristics of the study population are
summarized in Table 1. Of the 362 subjects recruited for
participation in this study, 66 were excluded because of
high blood pressure, BMIs exceeding 35 kg/m2 or ventilatory
impairment. Of the 296 remaining subjects, 58 (i.e., 20%)
were selected as controls. The remaining population was
composed of 127 males and 111 females, with a mean age
of 29.3  8.1 years. The ages of females and males were
similar. However, the females were overall shorter and
leaner than the males. Male and female subjects exhibitedTable 1 Characteristics of the study population.
Variables Male (nZ 127) Female (nZ 111)
Mean  SD Mean  SD
Age (years)* 28  8 30  8
Height (cm)z 170  5 157  6
Weight (kg)z 76  13 64  13
BMI (kg/m2) 26  4 26  5
HR (T0) 79  11 81  9
HR (T6)y 85  13 90  12
% mHR (T0)* 41  6 42  5
% mHR (T6)y 45  7 47  6
Borg (T0) 0  0 0  0
Borg (T6)* 0.1  0 0.4  1
Predicted FVC% 119  20 118  23
Predicted FEV1% 124  21 125  24
FEV1/FVC ratio 113  8 110  8
6MWD (m)z 430  47 386  46
Abbreviations: BMI, body mass index; HR, heart rate (i.e.,
expressed as beats/min); % mHR, percentage of maximum
predicted heart rate; T0, measurement taken at the beginning
of the test; T6, measurement taken at end of the test; FVC%,
parentage of predicted forced vital capacity; FEV1%,
percentage of predicted forced expiratory volume in 1 s.
* p < 0.05.
y p < 0.01.
z p < 0.001.similar spirometric measurements and basal heart rates. On
the other hand, we observed small but significant differ-
ence between the two groups with regards to Borg values
and post-test heart rates. Male and female subjects
reached 44% and 47% of their maximum predicted heart
rates, respectively, at the end of the test.
The overall mean walking distance was 410  52 m, with
significantly longer distances walked by males (i.e.,
430  48 m) than females (i.e., 386  46 m) (p < 0.0001;
95% CIZ  53 to 32). There were significant positive
correlations between 6MWD and height (i.e., rZ 0.485,
p < 0.0001), and 6MWD and weight (i.e., rZ 0.219,
p < 0.0001). However, female gender, age, maximum pre-
dicted heart rate and Borg values negatively correlated
with 6MWD (i.e., rZ  425, p < 0.001; rZ  0.289,
p < 0.001; rZ  0.123, pZ 0.034 and rZ  0.118,
pZ 0.043, respectively). BMI was more linearly associated
with 6MWD in females than in males. Female subjects with
BMIs greater than 25 kg/m2 walked shorter distances, while
a positive correlation was observed between walking
distance and females with BMIs less than 25 kg/m2.
A multiple linear stepwise regression analysis model was
used to predict 6MWD by subject’s height (i.e., p < 0.001; 95%
CIZ 2.11e3.12) and age (i.e., pZ 0.032; 95% CIZ  1.52 to
0.07) (Fig. 1). Approximately one-fourth of the variability in
6MWDwas explained by two variables (i.e., r2Z 0.250). Based
on the results of correlation and regression analyses, the 6MWD
for males and females can be determined by 6MWDZ
(2.81  height) þ (0.79  age) 28.5, where 6MWD is
expressed in meters, age in years and height in centimeters.
Thisequationaccuratelypredicted thedistanceswalkedbythe
control group (i.e., measured 6MWDZ 407.5  48 m and
predicted 6MWDZ 408.3  30 m, with mean differences of
0.82  44 m, pZ 0.89; 95% CIZ  12.6 to 10.9) (Fig. 2).
Fig. 3 compares our predicted 6MWD values with those of
five previously published studies. Walk distance was over-
estimated by all of the previously published equations,
including Troosters et al.,10 who overestimated the
distance walked by Saudis by 340  72 m (p < 0.001),
Camarri et al.13 by 334  51 m (p < 0.001), Gibbons et al.12
by 330  74 m (p < 0.001), Enright et al.11 by 278  73 m
(p < 0.001) and Poh et al.14 by 106  81 m (p < 0.001).Discussion
The 6MWT has been studied in several healthy populations,
including those in the Western hemisphere and Asia. This
study sought to define the mean age-predicted 6MWD of
a healthy Saudi population and compare this value with
those generated by previously reported regression equa-
tions. To our knowledge, this is the first study to predict
6MWD in people of Arabic descent, particularly those living
in Saudi Arabia.
The 6MWD reference value determined here was
substantially lower than previously reported values, which
overestimated the Saudi walking distance by 106e340 m.
Consistent with our study design, Enright et al. described
a 6MWD reference equation for 290 healthy subjects
between the ages of 40 and 80 years using single test
protocol in the studied cohort.11 However, that study
determined that men walked an average of 576 m and
Figure 1 The relationships between (a) 6MWD and age (i.e., rZ  0.219, pZ 0.001) and (b) 6MWD and height (i.e., rZ 0.485,
p < 0.001).
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these values to be 430 m and 386 m, respectively. These
differences do not reflect variations in age, height or
ventilatory function. Furthermore, Enright recruited
patients who were relatively older than our cohort. With
regards to pulmonary function, all of our subjects exhibited
normal spirometric parameters, excluding the possibility of
differences in ventilatory function. Thus, it is possible that
this discrepancy reflects differences in the submaximal
effort exerted by our subjects compared with those in the
Enright study. Our male and female subjects reached an
average of 44% and 47% of their maximum predicted heart
rates, respectively; while subjects in the Enright cohort
reached average of 61e65% of their mHRs.
Studies of exercise physiology have revealed a direct
relationship between muscle strength and physical exer-
cise. Decreased physical activity (i.e., inactivity) usually
leads to altered muscle metabolism, decreases in muscle
mass and lower physical capacity.21 This relation is more
obvious among patients with comorbid conditions, in which
the rate of inactivity correlates significantly with
6MWD.22,23 Local data suggest there is a high prevalence of
physical inactivity among Saudis, particularly those who areFigure 2 Actual measured 6MWD and predicted 6MWD
calculated with the proposed equation (d) with a 95% confi-
dence interval (....).middle-aged.24,25 Al-Refaee et al. reported inactivity in up
to 80% of 1333 randomly selected adult Saudi males, which
exceeds values reported for other Westernized countries.26
These observations support the idea that differences in the
reported 6MWD of Saudis and other populations may stem
from higher rates of physical inactivity (i.e., which subse-
quently affect muscle mass and strength) rather than
anthropometric characteristics.
Consistent with previous studies, we found that height
most strongly correlated with 6MWD and was the predom-
inant variable in the regression equation for male and
female subjects. Previous reports have attributed the
relationship between height and walked distance to
increased leg length, which generates a longer
stride.10,11,14 In contrast, weight had a minimum effect on
6MWD and was not represented in the final regression
equation. Previous reports of the relationship between
weight and 6MWD have been inconsistent. Thus, our results
do not necessary contradict previous studies, as most found
weight to be a strong predictor of 6MWD in populations
older than our cohort (i.e., older than 40 years).10,11,14 In
a study of 79 healthy subjects older than 20 years, weight
did not correlate with distance,12 suggesting that weight isFigure 3 Comparison of actual and predicted 6MWDs from
our study and five previous studies. Saudi walking distance was
overestimated by 106e340 m in all five of the previous studies.
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correlated significantly with 6MWD, it was not represented
in our final regression equation. Similar findings were
reported in a recent study, wherein height, age and pre-
dicted maximum heart rate were the only variables in the
final equation and no differences were observed between
6MWD in male and female subjects.14 Twenty five percent
of the variability of 6MWD in the current study was
explained by age and height. The low variability of our
equation is consistent with the findings of previous
studies.12,13 As exercise involves complex interactions
between the cardiovascular, respiratory and neuromuscular
systems, it is likely that most previously published 6MWT
reference equations, as well as our equation presented
here, lack sufficient variables to sensitively describe the
effects of exercise. However, our equation was able to
estimate the distance walked within an acceptable range of
error when applied to 20% of the recruited sample.
This study was limited by several factors. We did not
recruit individuals older than 50 years, due to the high
prevalence of hypertension, diabetes mellitus and hyper-
lipidemia in our local elderly population. Thus, our cohort
consisted of middle-aged subjects to eliminate the possi-
bility of subjects with confounding diseases that could
affect their walking ability.27 In addition, several investi-
gators have demonstrated the ‘‘learning effect’’
phenomena in 6MWT, wherein repeating the test more than
once significantly increases walking distance. Repetition
may be important for cardiopulmonary rehabilitation
programs, where it is necessary to familiarize patients with
the test. However, we theorized that the single test
method was more appropriate for clinical settings, where
the test will typically be performed once. Another potential
limitation is that the sample studied may not be repre-
sentative of the entire Saudi population. However, in view
that Riyadh is the largest city and a major commercial
center of Saudi Arabia that attracts workers, students and
visitors from different parts of the country, we believe that
the sample and therefore the study results can be extrap-
olated to the rest of the Saudi population. Finally, we did
not assess other potential variables that may have limited
physical function, such as daily physical activities, periph-
eral muscle strength and psychological factors.28
In conclusion, this study highlights the differences in
6MWD between Saudis and Caucasians. Our regression
equation will prove useful in future assessments of func-
tional status. As several other studies have shown a corre-
lation between 6MWD and mortality with regards to various
cardiopulmonary conditions, our study represents the first
step toward establishing a new set of 6MWD values that will
aid the development of diagnostic and prognostic markers
for these conditions in the Saudi population.
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